Disease management
A paper published in the Journal of Medical Extended Reality outlines how AI, generative virtual reality and multilingual voice cloning may help pain management.
The company will use the funds to increase the development of its computational platform to predict patient treatment responses and support drug research & development.
Western Sydney Diabetes adopts the mobile solution to automate patient engagement.
The funding brings the company's Series C funding round to a close and total capital raised to $155 million.
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.
The chronic care management and remote patient monitoring company will be led by veteran healthcare executive Asif Ahmad.
The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.
The company will use the funds to accelerate the commercialization of its TAPS therapy and enhance the visibility of its offerings among providers and patients.
The company will use the funds to expand its commercial growth and clinical-evidence generation.
Individuals can check whether the musculoskeletal platform is covered via their employer or health plan on Amazon's platform - and, if eligible, connect with Hinge's care team.